Silver in Cosmetic Products: What the UK SAG-CS Final Opinion Means for Manufacturers 

Final UK SAG-CS Silver Opinion: Key Implications for Cosmetic Manufacturers  

Ingredients used in cosmetics may transition from technically acceptable to regulatory focus due to new toxicological data, new classification or safety assessments.  

Silver is a case in point.  

The UK Scientific Advisory Group on Chemical Safety of Non-Food and Non-Medicinal Consumer Products (SAG-CS) has published its Final Opinion on Silver in Cosmetic Products, which is an important regulatory and safety assessment of micron-sized particulate silver in cosmetic products.  

The UK SAG-CS silver opinion is of special importance for cosmetic manufacturers and brand owners who incorporate silver as a colorant, antimicrobial or other functional component in cosmetic products. It also illustrates how the form of the ingredient, particle size, concentration, and mode of exposure to the product, as well as the product type, can affect the regulatory risk assessment.  

It is important for companies that are marketing or intending to market cosmetics with silver in Great Britain to take a closer look at the development..  

What does the final opinion cover?  

The UK SAG-CS silver opinion focuses specifically on micron-sized particulate silver with a particle diameter greater than 100 nm and less than 1 mm.  

The assessment considered the safety of this form of silver in cosmetic products following concerns arising from its classification under the GB Classification, Labeling and Packaging (CLP) Regulation.  

Silver in massive, powder, and nano forms has classifications including Reproductive Toxicity Category 2 and Specific Target Organ Toxicity, Repeated Exposure Category 2 under GB CLP. Silver powder and silver nano also carry aquatic toxicity classifications.  

Under the UK Cosmetics Regulation, the use of Category 1A, 1B, or 2 CMR substances is generally prohibited unless an exemption has been granted.  

This created the need for a specific safety assessment of micron-sized particulate silver intended for cosmetic use.  

Why is particle size important?

One of the most important points in the opinion is that not all forms of silver should be treated as regulatory equivalents.  

The material assessed by SAG-CS was described as a porous, sintered, micron-sized silver material. The submitted characterisation data showed no free nanoparticles, and the material was determined not to meet the UK Cosmetics Regulation or UK REACH definition of a nanomaterial.  

This distinction matters.  

Silver nanoparticles and micron-sized particulate silver can have different exposure and toxicological profiles. The SAG-CS specifically noted that the genotoxic potential reported for silver nanoparticles was outside the scope of this opinion because nanoparticles were not the material being assessed.  

For manufacturers, this reinforces a broader regulatory principle:  

The identity and physical characteristics of an ingredient matter just as much as its INCI name or chemical identity.  

A change in particle size, form, composition, or manufacturing specification can potentially change the regulatory assessment.  

What did the UK SAG-CS opinion conclude?  

After considering the available toxicological, exposure, and dermal absorption data, SAG-CS concluded that micron-sized particulate silver is acceptable for use in cosmetic products at specified maximum concentrations.  

The final maximum concentrations are:  

These conclusions apply specifically to the micron-sized particulate silver assessed in the opinion. Propellant-based spray products are excluded, because this product type was not included in the applicant's dossier.  

That last point is particularly important for manufacturers.  

The conclusion should not be interpreted as a blanket approval for every silver-containing cosmetic formulation or every form of silver.  

What does the safety assessment tell us?  

The SAG-CS final opinion considered exposure through dermal, oral, and inhalation routes.  

The submitted dermal penetration studies indicated that the micron-sized silver particles did not penetrate beyond the stratum corneum. However, SAG-CS still considered the potential absorption of silver ions and applied a conservative dermal absorption value of 0.1% for the safety assessment.  

The committee also considered the potential for inhalation exposure from spray products. Based on the available information, micron-sized silver was not expected to cause local toxicity in the lower respiratory tract when used in pump spray products. However, the committee explicitly excluded propellant-based sprays from its conclusion.  

The overall exposure assessment estimated a systemic exposure dose of 0.000037 mg/kg body weight/day across the assessed oral, dermal, and inhalation exposure routes under a conservative scenario.  

SAG-CS also acknowledged that silver is a reproductive toxicant but concluded that, considering the low systemic exposure associated with the assessed cosmetic uses and the available toxicological data, reproductive toxicity was unlikely to pose a concern for micron-sized silver at the evaluated uses.  

What does this mean for cosmetic manufacturers?  

The opinion provides greater clarity, but it does not eliminate the need for a product-specific regulatory assessment.  

Companies using silver in cosmetic formulations should look beyond simply checking whether "silver" appears in a permitted ingredient or colourant list.  

A practical review should consider at least five areas.  

1. Confirm the form of silver 
   Is the ingredient micron-sized particulate silver, nanosilver, a silver salt, or a silver-containing active substance?
   The SAG-CS final opinion applies specifically to micron-sized particulate silver. Other forms may be subject to different regulatory considerations and safety assessments.
2. Verify particle-size specifications 
   The final opinion places considerable importance on the characterisation of the material and the absence of free nanoparticles.  
   Manufacturers should therefore ensure that supplier specifications and technical documentation adequately establish the identity and physical characteristics of the silver ingredient being used.  
3. Check concentration against product type 
   The applicable maximum concentration depends on the intended cosmetic use.  
   A formulation containing 0.3% silver may fall within the conclusion for certain leave-on or rinse-off products, while the same concentration would not align with the stated maximum for lip products or oral care products.  
4. Assess exposure routes 
   Cosmetic safety assessment cannot be separated from how the product is used. 
   Dermal, oral, and inhalation exposure can differ substantially depending on the formulation and application method. Spray products deserve particular attention because the final opinion does not cover propellant-based sprays.   
5. Review the wider regulatory position 
   The SAG-CS assessment is one part of the regulatory picture. 
   Companies should also consider applicable requirements under the UK Cosmetics Regulation, GB CLP, and UK REACH, including ingredient documentation, safety assessment, and notification obligations, as applicable to the product and market.   

The bigger regulatory takeaway  

The UK SAG-CS silver opinion illustrates a broader challenge for the cosmetics industry.  

Ingredient compliance is not simply a yes-or-no exercise.   

The regulatory status of an ingredient can depend on:  

• Chemical identity  
• Physical form  
• Particle size  
• Nanomaterial status  
• Concentrazione  
• Categoria di prodotto  
• Intended function  
• Exposure route  
• Consumer population  
• Supporting toxicological data  

This becomes particularly important when an ingredient has multiple forms or functions across different cosmetic applications.  

For global cosmetic companies, the challenge becomes even greater when the same formulation is intended for multiple markets.  

A formulation that meets the requirements of one jurisdiction may require additional assessment, documentation, reformulation, or regulatory action elsewhere.  

What should companies do now?  

For brands and manufacturers with silver-containing products, this development presents an opportunity to strengthen regulatory control before products reach the market.  

A focused regulatory review can help companies:  

Identify where silver is used across the product portfolio.  

Characterise the exact form, particle size, and specification of the ingredient.  

Verify concentrations against the applicable product category.  

Review available safety and technical documentation.  

Assess exposure across relevant routes and consumer uses.  

Evaluate whether existing products and planned formulations remain aligned with applicable UK requirements.  

Monitor subsequent regulatory developments that could affect silver or other ingredients classified as CMR substances or nanomaterials.  

Why regulatory intelligence matters  

The silver case also demonstrates why regulatory monitoring should be part of ongoing cosmetic compliance, not a one-time pre-market activity.  

The UK assessment was developed through a series of regulatory and scientific events, such as prior SCCS assessments, as well as new information regarding dermal penetration. Following these ongoing regulatory and scientific advances, the final SAG-CS opinion was issued in August 2026. Managing large product portfolios with many ingredients, in multiple markets, makes it challenging for cosmetic companies to track regulatory and scientific developments by hand, determining whether they affect specific products, and translate regulatory developments into practical actions for cosmetics ingredient safety assessment, formulation, documentation, and market access.  

How does this impact your cosmetic portfolio?   

The SAG-CS final opinion on silver provides useful clarity for a specific form of silver, but the regulatory question for manufacturers is broader:  

Does the ingredient, formulation, intended use, and supporting documentation remain aligned with the requirements of every market where the product is sold?  

That’s where a portfolio-level regulatory assessment comes into play. 

From product formulation and ingredient review to safety and compliance assessments, market-specific regulatory requirements, and ongoing regulatory intelligence, a structured approach can help cosmetic companies identify compliance gaps before they become barriers to market access.  

Keep up with evolving cosmetic regulations. 

When regulations change, it can impact how you make your products, which ingredients you choose, the documentation you need, and even your plans to enter new markets.  

Freyr supports cosmetic companies with regulatory and compliance requirements across global markets, helping teams assess regulatory changes and translate them into actionable product and market decisions.  

Need support assessing how the latest silver regulatory developments could affect your cosmetic portfolio?  

Request a Safety Assessment